🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/04/2019 | 77,22 | 77,22 | 75,75 | 76,18 | -1,21% | 1,90% | 10.410.518 |
| 10/04/2019 | 77,16 | 77,60 | 76,96 | 77,12 | +0,02% | 0,83% | 6.894.268 |
| 09/04/2019 | 76,88 | 77,27 | 76,58 | 77,10 | -0,19% | 0,89% | 10.785.282 |
| 08/04/2019 | 77,25 | 77,54 | 76,67 | 77,24 | -0,25% | 1,12% | 10.586.267 |
| 05/04/2019 | 78,22 | 78,40 | 77,40 | 77,43 | -0,86% | 1,28% | 10.324.162 |
| 04/04/2019 | 79,21 | 79,39 | 77,49 | 78,10 | -1,60% | 2,40% | 10.257.719 |
| 03/04/2019 | 79,46 | 79,83 | 78,96 | 79,37 | -0,04% | 1,09% | 6.550.734 |
| 02/04/2019 | 79,64 | 79,89 | 79,10 | 79,40 | -0,11% | 0,98% | 5.875.088 |
| 01/04/2019 | 79,90 | 80,01 | 79,14 | 79,48 | +0,16% | 1,09% | 8.820.282 |
| 29/03/2019 | 79,20 | 79,48 | 78,92 | 79,36 | +0,65% | 0,71% | 10.147.994 |
| 28/03/2019 | 79,00 | 79,10 | 78,42 | 78,85 | +0,41% | 0,87% | 7.161.298 |
| 27/03/2019 | 79,12 | 79,26 | 78,06 | 78,52 | -0,76% | 1,51% | 10.020.766 |
| 26/03/2019 | 78,97 | 79,65 | 78,79 | 79,12 | +0,69% | 1,09% | 9.242.731 |
| 25/03/2019 | 78,31 | 78,96 | 78,17 | 78,58 | +0,07% | 1,01% | 7.878.654 |
| 22/03/2019 | 79,11 | 79,63 | 78,26 | 78,52 | -0,80% | 1,72% | 10.639.191 |
| 21/03/2019 | 78,34 | 79,36 | 78,10 | 79,15 | +1,06% | 1,61% | 9.473.291 |
| 20/03/2019 | 78,10 | 78,93 | 77,65 | 78,32 | +0,21% | 1,64% | 11.894.590 |
| 19/03/2019 | 77,81 | 78,24 | 77,25 | 78,16 | +0,69% | 1,28% | 10.224.393 |
| 18/03/2019 | 77,55 | 78,08 | 77,21 | 77,62 | -0,27% | 1,12% | 14.357.914 |
| 15/03/2019 | 77,77 | 78,16 | 77,10 | 77,83 | +0,10% | 1,36% | 17.341.046 |
| 14/03/2019 | 77,59 | 78,02 | 77,22 | 77,76 | -0,13% | 1,02% | 8.530.406 |
| 13/03/2019 | 77,87 | 78,25 | 77,47 | 77,86 | +0,46% | 1,00% | 8.059.749 |
| 12/03/2019 | 77,45 | 77,82 | 77,08 | 77,51 | +0,45% | 0,96% | 9.261.281 |
| 11/03/2019 | 76,68 | 77,32 | 76,40 | 77,17 | +1,34% | 1,19% | 9.126.613 |
| 08/03/2019 | 76,54 | 76,91 | 75,43 | 76,15 | -0,81% | 1,93% | 11.716.326 |
| 07/03/2019 | 77,32 | 77,40 | 76,37 | 76,77 | -0,38% | 1,32% | 10.925.505 |
| 06/03/2019 | 77,86 | 78,02 | 76,62 | 77,06 | -1,15% | 1,79% | 8.167.169 |
| 05/03/2019 | 77,75 | 78,27 | 77,50 | 77,96 | +0,41% | 0,99% | 8.698.190 |
| 04/03/2019 | 78,27 | 78,36 | 76,84 | 77,64 | -0,34% | 1,94% | 8.522.755 |
| 01/03/2019 | 78,02 | 78,18 | 77,45 | 77,91 | +0,44% | 0,93% | 10.624.205 |